Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
AC Immune SA (NASDAQ: ACIU)
ACIU Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
104.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
67.40%
ACIU Stock Analysis
ACIU
PE Ratio:
ACIU
PEG Ratio:
Not Available
ACIU
Forward EPS Growth (12 month):
0.00%
ACIU
PS Ratio:
51.2
ACIU
PSG Ratio:
0.4
ACIU
Forward Revenue Growth (12 month):
138.90%
ACIU Articles
No data was found